Xiao X Wei

13PUBLICATIONS
140CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)PharmacogenomicsRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 18, 2026
Longitudinal Phenotyping of Circulating Tumor Cells using a Scalable Deep Learning Framework.

|Jul 01, 2026
Long-term follow-up from the OMNIVORE trial: response-adaptive nivolumab and ipilimumab in advanced renal cell carcinoma.

|Mar 04, 2026
Phase I Trial of P-PSMA-101 CAR T Cells in Patients with Metastatic Castration-Resistant Prostate Cancer.

Susan Slovin, Xin Gao, Xiao X Wei

|Feb 13, 2025
Examining Patient Characteristics in Bladder Cancer Clinical Trials Involving Immunotherapy.

Izuagie Ikhapoh, Usomine Atairu, Amanda Jane Reich

|Feb 06, 2025
High-purity CTC RNA sequencing identifies prostate cancer lineage phenotypes prognostic for clinical outcomes.

Marina N Sharifi, Jamie M Sperger, Amy K Taylor

|Aug 20, 2024
Quantitative 68Ga-PSMA-11 PET and Clinical Outcomes in Metastatic Castration-resistant Prostate Cancer Following 177Lu-PSMA-617 (VISION Trial).

Phillip H Kuo, Michael J Morris, Jacob Hesterman

Pageof 3

Frequent Collaborators

6 joint publications

Rana R McKay

4 joint publications

Christos Kyriakopoulos

4 joint publications

Jamie M Sperger

4 joint publications

Atish D Choudhury